Iovance Biotherapeutics, Inc. (IOVA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
IOVA Q1 2026: Ampagni Revenue Up 38% as TIL Platform Expands Clinical Reach
May 07, 2026
-
IOVA Q4 2025: MTAGV Drives 30% Revenue Growth as Pipeline Expansion Accelerates
February 25, 2026
-
IOVA Q3 2025: Gross Margin Climbs to 43% as Internal Manufacturing Shift Accelerates Path to Profitability
November 06, 2025
-
IOVA Q2 2025: 19% Workforce Cut Targets Margin Lift as TIL Therapy Adoption Climbs
August 08, 2025
-
IOVA Q1 2025: Gross Margin Slumps to 10% Amid Manufacturing Disruptions and Revised Guidance
July 05, 2025